Efrat Ozeri-Galai - Dept Genet, Hebrew Univ Jerusalem

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

WS09.03 Delivery Characterisation of SPL84 Inhaled Antisense Oligonucleotide

E. Ozeri-Galai, L. Friedman,M. Markovetz, W. Boone,G. Hart,K. Rouillard,D. Hill,A. Faerman, C. Stamper,Y. Oren,S. Tilley, C. Jania

Journal of Cystic Fibrosis (2023): S18-S19

引用0浏览0引用

235 Reducing MUC5AC or MUC5B Expression Using Antisense Oligonucleotides As a Therapeutic Approach for Cystic Fibrosis and Other Muco-Obstructive Diseases

Y. Oren,C. Stampfer,R. Elgrabli,T. Blinder, M. Ordan, S. Jubeh,T. Mordechai,S. Dahan,B. Kerem, G. Hart,E. Ozeri-Galai

Journal of Cystic Fibrosis (2023)

引用0浏览0引用

P014 Safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide cystic fibrosis therapeutic

Gili Hart, O. Barchad-Avitzur, Lee Friedman,Shani Dahan, T. Moedechai,E. Ozeri-Galai, Anna Cohen

Journal of Cystic Fibrosis (2023): S67-S68

引用0浏览0引用

231 Safety and Toxicity Profile of SPL84, an Inhaled Antisense Oligonucleotide for Treatment of People with Cystic Fibrosis with the 3849 +10 Kb C- >T Mutation to Support Phase 1/2a Clinical Study

L. Friedman, O. Barchad-Avitzur,S. Dahan,T. Mordechai,E. Ozeri-Galai, A. Cohen, G. Hart

Journal of Cystic Fibrosis (2023): S118

引用0浏览0引用

236 SPL84, an Antisense Oligonucleotide Modulating the 3849+10 Kb C-T Splicing Defect, Efficiently Penetrates and Restores CFTR Function when Treated Through the Apical Side of Primary Human Bronchial Epithelial Cells

O. Barchad-Avitzur, Y. Oren,C. Stampfer,E. Ozeri-Galai, G. Hart,B. Kerem

Journal of Cystic Fibrosis (2023): S121

引用0浏览0引用

Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849+10 Kb C- > T Cystic Fibrosis Patients

Efrat Ozeri-Galai,Lital Friedman,Ofra Barchad-Avitzur,Matthew R. Markovetz,William Boone,Kaitlyn R. Rouillard,Chava D. Stampfer,Yifat S. Oren,David B. Hill,Batsheva Kerem,Gili Hart

Nucleic acid therapeutics（2023）

引用2浏览0WOS引用

Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide

Efrat Ozeri-Galai,Lital Friedman, Ofra-Barchad-Avitzur,Matthew R Markovetz,William Boone,Kaitlyn R Rouillard,Chava D Stampfer,Yifat S Oren,David B Hill,Batsheva Kerem,Gili Hart

medRxiv (Cold Spring Harbor Laboratory) (2023)

引用0浏览0引用

Antisense Oligonucleotide Splicing Modulation As a Novel Cystic Fibrosis Therapeutic Approach for the W1282X Nonsense Mutation

Yifat S. Oren, Ofra Avizur-Barchad,Efrat Ozeri-Galai, Renana Elgrabli, Meital R. Schirelman, Tehilla Blinder,Chava D. Stampfer, Merav Ordan,Onofrio Laselva,Malena Cohen-Cymberknoh,Eitan Kerem,Christine E. Bear,Batsheva Kerem

Journal of cystic fibrosisno. 4 (2022): 630-636

引用6浏览0WOS引用

601: Antisense-oligonucleotide-splicing modulation as a novel CF therapeutic approach for W1282X mutation

B. Kerem, Y. Oren, O. Avizur-Barchad,E. Ozeri-Galai,R. Elgrabli, M. Schirelman, T. Fogel, M. Ordan,O. Laselva,E. Kerem,C. Bear

Journal of Cystic Fibrosis（2021）

引用0浏览0引用

P034 Novel insights into the therapeutic potential of antisense oligonucleotides as splicing modulators in respiratory and intestinal patient-derived model systems

N. Stanleigh, M. Irony-Tur Sinai, Y. Oren,A. Golec,A. Hatton, O. Avizur-Barchad,E. Ozeri-Galai,M. Wilschanski,E. Kerem,I. Sermet-Gaudelus,B. Kerem

Journal of Cystic Fibrosis（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn